Review



picrosirius red  (StatLab Medical Products Inc)


Bioz Verified Symbol StatLab Medical Products Inc is a verified supplier
Bioz Manufacturer Symbol StatLab Medical Products Inc manufactures this product  
  • Logo
  • About
  • News
  • Press Release
  • Team
  • Advisors
  • Partners
  • Contact
  • Bioz Stars
  • Bioz vStars
  • 90

    Structured Review

    StatLab Medical Products Inc picrosirius red
    ( A ) Schematic and endoscopy images of endoscopy-guided intracordal injection and vocal fold (VF) scarring rat model. ( B ) Hematoxylin & eosin (H&E) and ( C ) hyaluronan binding protein (HABP) histology of rat larynges injected with blank hyaluronic acid MGs show successful intracordal injection of the underlying vocalis muscle. Dotted outlines are drawn around injected microgels. ( D ) H&E staining of mid-coronal vocal fold sections suggests a denser extracellular matrix in scarred VFs left untreated or injected with blank microgels relative to healthy rats and injured rats injected with DCN-loaded microgels at 7 days post-injury. ( E&G ) <t>Picrosirius</t> red staining visualized by polarized light microscopy show that VF scarring is characterized by significant collagen accumulation, which is unaffected by injection of blank microgels. DCN-loaded microgels were sufficient to prevent collagen accumulation. Dotted outlines drawn around the VF lamina propria for each representative image. ( F&H ) DCN-MGs mitigates persistent myofibroblast activation in vivo as evidenced by reduced α-SMA (myofibroblast marker) immunostaining in vivo. Dotted outlines drawn around the VF lamina propria for each representative image. *=p<0.05, **=p<0.01
    Picrosirius Red, supplied by StatLab Medical Products Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/picrosirius red/product/StatLab Medical Products Inc
    Average 90 stars, based on 1 article reviews
    picrosirius red - by Bioz Stars, 2026-03
    90/100 stars

    Images

    1) Product Images from "Controlled decorin delivery from injectable microgels promotes scarless vocal fold repair"

    Article Title: Controlled decorin delivery from injectable microgels promotes scarless vocal fold repair

    Journal: bioRxiv

    doi: 10.1101/2025.06.25.661429

    ( A ) Schematic and endoscopy images of endoscopy-guided intracordal injection and vocal fold (VF) scarring rat model. ( B ) Hematoxylin & eosin (H&E) and ( C ) hyaluronan binding protein (HABP) histology of rat larynges injected with blank hyaluronic acid MGs show successful intracordal injection of the underlying vocalis muscle. Dotted outlines are drawn around injected microgels. ( D ) H&E staining of mid-coronal vocal fold sections suggests a denser extracellular matrix in scarred VFs left untreated or injected with blank microgels relative to healthy rats and injured rats injected with DCN-loaded microgels at 7 days post-injury. ( E&G ) Picrosirius red staining visualized by polarized light microscopy show that VF scarring is characterized by significant collagen accumulation, which is unaffected by injection of blank microgels. DCN-loaded microgels were sufficient to prevent collagen accumulation. Dotted outlines drawn around the VF lamina propria for each representative image. ( F&H ) DCN-MGs mitigates persistent myofibroblast activation in vivo as evidenced by reduced α-SMA (myofibroblast marker) immunostaining in vivo. Dotted outlines drawn around the VF lamina propria for each representative image. *=p<0.05, **=p<0.01
    Figure Legend Snippet: ( A ) Schematic and endoscopy images of endoscopy-guided intracordal injection and vocal fold (VF) scarring rat model. ( B ) Hematoxylin & eosin (H&E) and ( C ) hyaluronan binding protein (HABP) histology of rat larynges injected with blank hyaluronic acid MGs show successful intracordal injection of the underlying vocalis muscle. Dotted outlines are drawn around injected microgels. ( D ) H&E staining of mid-coronal vocal fold sections suggests a denser extracellular matrix in scarred VFs left untreated or injected with blank microgels relative to healthy rats and injured rats injected with DCN-loaded microgels at 7 days post-injury. ( E&G ) Picrosirius red staining visualized by polarized light microscopy show that VF scarring is characterized by significant collagen accumulation, which is unaffected by injection of blank microgels. DCN-loaded microgels were sufficient to prevent collagen accumulation. Dotted outlines drawn around the VF lamina propria for each representative image. ( F&H ) DCN-MGs mitigates persistent myofibroblast activation in vivo as evidenced by reduced α-SMA (myofibroblast marker) immunostaining in vivo. Dotted outlines drawn around the VF lamina propria for each representative image. *=p<0.05, **=p<0.01

    Techniques Used: Injection, Binding Assay, Staining, Light Microscopy, Activation Assay, In Vivo, Marker, Immunostaining



    Similar Products

    94
    Chondrex Inc picrosirius red staining kit
    Picrosirius Red Staining Kit, supplied by Chondrex Inc, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/picrosirius red staining kit/product/Chondrex Inc
    Average 94 stars, based on 1 article reviews
    picrosirius red staining kit - by Bioz Stars, 2026-03
    94/100 stars
      Buy from Supplier

    99
    Advisains picro-sirius red solution
    Picro Sirius Red Solution, supplied by Advisains, used in various techniques. Bioz Stars score: 99/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/picro-sirius red solution/product/Advisains
    Average 99 stars, based on 1 article reviews
    picro-sirius red solution - by Bioz Stars, 2026-03
    99/100 stars
      Buy from Supplier

    90
    BIOSTAIN READY REAGENTS LIMITED picrosirius red solution
    ROCK2 inhibition with GV101 reduces CAF-mediated remodelling of pre-existing collagen in murine and human models of TNBC, also see Figures S1 and S2 (A) Schematic of collagen contraction assays utilising CAFs isolated from end-stage MMTV-PyMT tumours. (B) Representative images of PyMT CAF matrices treated with DMSO, GV101 or Fasudil at days 3 and 12 of contraction (i) and quantification of PyMT CAF organotypic matrix size over a 12-day contraction period (ii) and on day 12 (iii). (C) Representative SHG images of PyMT CAF matrices to assess collagen I (top panel, magenta), <t>picrosirius</t> red staining to assess fibrillar collagen (middle panel) and polarised light birefringence imaging to assess collagen bundling and density (bottom panel). (D) Quantification of unconfined compression analysis to assess Young’s modulus. (E-G) Quantification of PyMT CAF matrices; SHG peak signal intensity (E), picrosirius red staining coverage (F) and total birefringence signal (G). (H) Schematic of collagen contraction assays utilising CAFs isolated from human TNBC patients. (I) Representative images of human CAF matrices treated with DMSO, GV101 or Fasudil at days 3 and 12 of contraction (i) and quantification of CAF organotypic matrix size over a 12-day contraction period (ii) and on day 12 (iii). (J) Representative SHG images of human CAF matrices to assess collagen I (top panel, magenta), picrosirius red staining to assess fibrillar collagen (middle panel) and polarised light birefringence imaging to assess collagen bundling and density (bottom panel). (K) Quantification of unconfined compression analysis to assess matrix Young’s modulus. (L-N) Quantification of human CAF matrices; SHG peak signal intensity (L), picrosirius red staining coverage (M) and total birefringence signal (N). Data represents mean ± SEM of three individual repeats. p-values were determined using One-sample t and Wilcoxon test for normalised data and for remaining data a One-way ANOVA with multiple comparisons was used. ns = not significant (p≥0.05), * = p<0.05, ** = p<0.01, *** = p<0.001, **** = p<0.0001. Scale bar = 1cm (B and I), 100µm (C and J).
    Picrosirius Red Solution, supplied by BIOSTAIN READY REAGENTS LIMITED, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/picrosirius red solution/product/BIOSTAIN READY REAGENTS LIMITED
    Average 90 stars, based on 1 article reviews
    picrosirius red solution - by Bioz Stars, 2026-03
    90/100 stars
      Buy from Supplier

    90
    StatLab Medical Products Inc picrosirius red
    ( A ) Schematic and endoscopy images of endoscopy-guided intracordal injection and vocal fold (VF) scarring rat model. ( B ) Hematoxylin & eosin (H&E) and ( C ) hyaluronan binding protein (HABP) histology of rat larynges injected with blank hyaluronic acid MGs show successful intracordal injection of the underlying vocalis muscle. Dotted outlines are drawn around injected microgels. ( D ) H&E staining of mid-coronal vocal fold sections suggests a denser extracellular matrix in scarred VFs left untreated or injected with blank microgels relative to healthy rats and injured rats injected with DCN-loaded microgels at 7 days post-injury. ( E&G ) <t>Picrosirius</t> red staining visualized by polarized light microscopy show that VF scarring is characterized by significant collagen accumulation, which is unaffected by injection of blank microgels. DCN-loaded microgels were sufficient to prevent collagen accumulation. Dotted outlines drawn around the VF lamina propria for each representative image. ( F&H ) DCN-MGs mitigates persistent myofibroblast activation in vivo as evidenced by reduced α-SMA (myofibroblast marker) immunostaining in vivo. Dotted outlines drawn around the VF lamina propria for each representative image. *=p<0.05, **=p<0.01
    Picrosirius Red, supplied by StatLab Medical Products Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/picrosirius red/product/StatLab Medical Products Inc
    Average 90 stars, based on 1 article reviews
    picrosirius red - by Bioz Stars, 2026-03
    90/100 stars
      Buy from Supplier

    90
    PanReac AppliChem picrosirius red stain
    ( A ) Schematic and endoscopy images of endoscopy-guided intracordal injection and vocal fold (VF) scarring rat model. ( B ) Hematoxylin & eosin (H&E) and ( C ) hyaluronan binding protein (HABP) histology of rat larynges injected with blank hyaluronic acid MGs show successful intracordal injection of the underlying vocalis muscle. Dotted outlines are drawn around injected microgels. ( D ) H&E staining of mid-coronal vocal fold sections suggests a denser extracellular matrix in scarred VFs left untreated or injected with blank microgels relative to healthy rats and injured rats injected with DCN-loaded microgels at 7 days post-injury. ( E&G ) <t>Picrosirius</t> red staining visualized by polarized light microscopy show that VF scarring is characterized by significant collagen accumulation, which is unaffected by injection of blank microgels. DCN-loaded microgels were sufficient to prevent collagen accumulation. Dotted outlines drawn around the VF lamina propria for each representative image. ( F&H ) DCN-MGs mitigates persistent myofibroblast activation in vivo as evidenced by reduced α-SMA (myofibroblast marker) immunostaining in vivo. Dotted outlines drawn around the VF lamina propria for each representative image. *=p<0.05, **=p<0.01
    Picrosirius Red Stain, supplied by PanReac AppliChem, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/picrosirius red stain/product/PanReac AppliChem
    Average 90 stars, based on 1 article reviews
    picrosirius red stain - by Bioz Stars, 2026-03
    90/100 stars
      Buy from Supplier

    90
    Servicebio Inc picrosirius red staining
    An AAV.CPP.16-mediated gene therapy for idiopathic pulmonary fibrosis (A) Schematic diagram illustrating design of a bifunctional fusion protein that inhibits VEGF and TGF-β1 and construction of an AAV vector expressing such a protein. (B) Experimental design for testing the AAV.CPP.16 gene therapy (CPP.16-IPF trap) in a bleomycin-induced IPF mouse model. i.t., intratracheal; inhal., Inhaled; i.g., intragastric. (C) Representative H&E staining on lung sections in mice with different treatments. Scale bar: 200 μm for low-magnification images and 50 μm for enlarged images. (D) Quantification of lung cell areas in H&E-stained lung sections. n = 3–6 per group, mean ± SEM, one-way ANOVA with Tukey’s post-test. (E) Representative Masson, <t>picrosirius</t> red, and αSMA immunohistochemical staining of lung sections in mice with different treatments. Masson (blue) and picrosirius red (red) stainings label collagen expression. Scale bar: 200 μm. (F) Quantification of fibrotic areas on lung sections. n = 3–6 per group, mean ± SEM, one-way ANOVA with Tukey’s post-test. ∗ p < 0.05, ∗∗ p < 0.01, ∗∗∗ p < 0.001. PBS, phosphate-buffered saline; BLM, bleomycin; IPF, idiopathic pulmonary fibrosis; PFD, pirfenidone; H&E, hematoxylin and eosin.
    Picrosirius Red Staining, supplied by Servicebio Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/picrosirius red staining/product/Servicebio Inc
    Average 90 stars, based on 1 article reviews
    picrosirius red staining - by Bioz Stars, 2026-03
    90/100 stars
      Buy from Supplier

    90
    Morphisto GmbH picrosirius red
    ( a ) F-ε z fitting before (red) and after (green) apparent Poisson’s ratio correction. ( b ) Lateral strain ε x as a function of compressive strain ε z . The red and green curves represent the computed lateral strain assuming incompressibility and compressibility, respectively. The black dots were obtained from the CS image segmentation and shape analysis. Error bars represent standard deviation ( n = 6), ( c ) Sensitivity of the apparent modulus calculated at 0.5 μm/s displacement rate to variations in apparent Poisson’s ratio, ( d ) Confocal fluorescence images of a CS composed of human primary cardiac fibroblasts, stained with BioTracker 488 (cell body, green), Hoechst 33342 (cell nuclei, blue) and <t>Picrosirius</t> red (collagen fibrils, red). Showing a maximum intensity projection of a 70 μm z-stack.
    Picrosirius Red, supplied by Morphisto GmbH, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/picrosirius red/product/Morphisto GmbH
    Average 90 stars, based on 1 article reviews
    picrosirius red - by Bioz Stars, 2026-03
    90/100 stars
      Buy from Supplier

    Image Search Results


    ROCK2 inhibition with GV101 reduces CAF-mediated remodelling of pre-existing collagen in murine and human models of TNBC, also see Figures S1 and S2 (A) Schematic of collagen contraction assays utilising CAFs isolated from end-stage MMTV-PyMT tumours. (B) Representative images of PyMT CAF matrices treated with DMSO, GV101 or Fasudil at days 3 and 12 of contraction (i) and quantification of PyMT CAF organotypic matrix size over a 12-day contraction period (ii) and on day 12 (iii). (C) Representative SHG images of PyMT CAF matrices to assess collagen I (top panel, magenta), picrosirius red staining to assess fibrillar collagen (middle panel) and polarised light birefringence imaging to assess collagen bundling and density (bottom panel). (D) Quantification of unconfined compression analysis to assess Young’s modulus. (E-G) Quantification of PyMT CAF matrices; SHG peak signal intensity (E), picrosirius red staining coverage (F) and total birefringence signal (G). (H) Schematic of collagen contraction assays utilising CAFs isolated from human TNBC patients. (I) Representative images of human CAF matrices treated with DMSO, GV101 or Fasudil at days 3 and 12 of contraction (i) and quantification of CAF organotypic matrix size over a 12-day contraction period (ii) and on day 12 (iii). (J) Representative SHG images of human CAF matrices to assess collagen I (top panel, magenta), picrosirius red staining to assess fibrillar collagen (middle panel) and polarised light birefringence imaging to assess collagen bundling and density (bottom panel). (K) Quantification of unconfined compression analysis to assess matrix Young’s modulus. (L-N) Quantification of human CAF matrices; SHG peak signal intensity (L), picrosirius red staining coverage (M) and total birefringence signal (N). Data represents mean ± SEM of three individual repeats. p-values were determined using One-sample t and Wilcoxon test for normalised data and for remaining data a One-way ANOVA with multiple comparisons was used. ns = not significant (p≥0.05), * = p<0.05, ** = p<0.01, *** = p<0.001, **** = p<0.0001. Scale bar = 1cm (B and I), 100µm (C and J).

    Journal: bioRxiv

    Article Title: ROCK2 inhibition has a dual role in reducing ECM remodelling and cell growth, while impairing migration and invasion

    doi: 10.1101/2025.07.21.666015

    Figure Lengend Snippet: ROCK2 inhibition with GV101 reduces CAF-mediated remodelling of pre-existing collagen in murine and human models of TNBC, also see Figures S1 and S2 (A) Schematic of collagen contraction assays utilising CAFs isolated from end-stage MMTV-PyMT tumours. (B) Representative images of PyMT CAF matrices treated with DMSO, GV101 or Fasudil at days 3 and 12 of contraction (i) and quantification of PyMT CAF organotypic matrix size over a 12-day contraction period (ii) and on day 12 (iii). (C) Representative SHG images of PyMT CAF matrices to assess collagen I (top panel, magenta), picrosirius red staining to assess fibrillar collagen (middle panel) and polarised light birefringence imaging to assess collagen bundling and density (bottom panel). (D) Quantification of unconfined compression analysis to assess Young’s modulus. (E-G) Quantification of PyMT CAF matrices; SHG peak signal intensity (E), picrosirius red staining coverage (F) and total birefringence signal (G). (H) Schematic of collagen contraction assays utilising CAFs isolated from human TNBC patients. (I) Representative images of human CAF matrices treated with DMSO, GV101 or Fasudil at days 3 and 12 of contraction (i) and quantification of CAF organotypic matrix size over a 12-day contraction period (ii) and on day 12 (iii). (J) Representative SHG images of human CAF matrices to assess collagen I (top panel, magenta), picrosirius red staining to assess fibrillar collagen (middle panel) and polarised light birefringence imaging to assess collagen bundling and density (bottom panel). (K) Quantification of unconfined compression analysis to assess matrix Young’s modulus. (L-N) Quantification of human CAF matrices; SHG peak signal intensity (L), picrosirius red staining coverage (M) and total birefringence signal (N). Data represents mean ± SEM of three individual repeats. p-values were determined using One-sample t and Wilcoxon test for normalised data and for remaining data a One-way ANOVA with multiple comparisons was used. ns = not significant (p≥0.05), * = p<0.05, ** = p<0.01, *** = p<0.001, **** = p<0.0001. Scale bar = 1cm (B and I), 100µm (C and J).

    Article Snippet: Slides were then incubated in 0.02% phosphomolybdic acid for 2 minutes and briefly washed in water before a 2 hour incubation in 0.1% Picrosirius Red solution (Australian Biostain solution).

    Techniques: Inhibition, Isolation, Staining, Imaging

    (A) Schematic of cell-derived matrix (CDM) production assays where both PyMT and human CAFs are treated with ascorbic acid to stimulate matrix production in the presence of DMSO, GV101 or Fasudil. (B) Representative images of PyMT CAF derived CDMs showing SHG imaging (top panel, magenta) and picrosirius red stained matrices (bottom panel). (C) Quantification of peak SHG signal (i) and picrosirius red staining coverage for PyMT CAF generated CDMs (ii). (D) Representative images of human CAF derived CDMs showing SHG imaging (top panel, magenta) and picrosirius red stained matrices (bottom panel). (E) Quantification of peak SHG signal (i) and picrosirius red coverage (ii) for human CAF generated CDMs. Data represents mean ± SEM of three individual repeats. p-values were determined using One-sample t and Wilcoxon test for normalised data and for remaining data a One-way ANOVA with multiple comparisons was used. ns = not significant (p≥0.05), * = p<0.05, ** = p<0.01. Scale bar = 100μm.

    Journal: bioRxiv

    Article Title: ROCK2 inhibition has a dual role in reducing ECM remodelling and cell growth, while impairing migration and invasion

    doi: 10.1101/2025.07.21.666015

    Figure Lengend Snippet: (A) Schematic of cell-derived matrix (CDM) production assays where both PyMT and human CAFs are treated with ascorbic acid to stimulate matrix production in the presence of DMSO, GV101 or Fasudil. (B) Representative images of PyMT CAF derived CDMs showing SHG imaging (top panel, magenta) and picrosirius red stained matrices (bottom panel). (C) Quantification of peak SHG signal (i) and picrosirius red staining coverage for PyMT CAF generated CDMs (ii). (D) Representative images of human CAF derived CDMs showing SHG imaging (top panel, magenta) and picrosirius red stained matrices (bottom panel). (E) Quantification of peak SHG signal (i) and picrosirius red coverage (ii) for human CAF generated CDMs. Data represents mean ± SEM of three individual repeats. p-values were determined using One-sample t and Wilcoxon test for normalised data and for remaining data a One-way ANOVA with multiple comparisons was used. ns = not significant (p≥0.05), * = p<0.05, ** = p<0.01. Scale bar = 100μm.

    Article Snippet: Slides were then incubated in 0.02% phosphomolybdic acid for 2 minutes and briefly washed in water before a 2 hour incubation in 0.1% Picrosirius Red solution (Australian Biostain solution).

    Techniques: Derivative Assay, Imaging, Staining, Generated

    ( A ) Schematic and endoscopy images of endoscopy-guided intracordal injection and vocal fold (VF) scarring rat model. ( B ) Hematoxylin & eosin (H&E) and ( C ) hyaluronan binding protein (HABP) histology of rat larynges injected with blank hyaluronic acid MGs show successful intracordal injection of the underlying vocalis muscle. Dotted outlines are drawn around injected microgels. ( D ) H&E staining of mid-coronal vocal fold sections suggests a denser extracellular matrix in scarred VFs left untreated or injected with blank microgels relative to healthy rats and injured rats injected with DCN-loaded microgels at 7 days post-injury. ( E&G ) Picrosirius red staining visualized by polarized light microscopy show that VF scarring is characterized by significant collagen accumulation, which is unaffected by injection of blank microgels. DCN-loaded microgels were sufficient to prevent collagen accumulation. Dotted outlines drawn around the VF lamina propria for each representative image. ( F&H ) DCN-MGs mitigates persistent myofibroblast activation in vivo as evidenced by reduced α-SMA (myofibroblast marker) immunostaining in vivo. Dotted outlines drawn around the VF lamina propria for each representative image. *=p<0.05, **=p<0.01

    Journal: bioRxiv

    Article Title: Controlled decorin delivery from injectable microgels promotes scarless vocal fold repair

    doi: 10.1101/2025.06.25.661429

    Figure Lengend Snippet: ( A ) Schematic and endoscopy images of endoscopy-guided intracordal injection and vocal fold (VF) scarring rat model. ( B ) Hematoxylin & eosin (H&E) and ( C ) hyaluronan binding protein (HABP) histology of rat larynges injected with blank hyaluronic acid MGs show successful intracordal injection of the underlying vocalis muscle. Dotted outlines are drawn around injected microgels. ( D ) H&E staining of mid-coronal vocal fold sections suggests a denser extracellular matrix in scarred VFs left untreated or injected with blank microgels relative to healthy rats and injured rats injected with DCN-loaded microgels at 7 days post-injury. ( E&G ) Picrosirius red staining visualized by polarized light microscopy show that VF scarring is characterized by significant collagen accumulation, which is unaffected by injection of blank microgels. DCN-loaded microgels were sufficient to prevent collagen accumulation. Dotted outlines drawn around the VF lamina propria for each representative image. ( F&H ) DCN-MGs mitigates persistent myofibroblast activation in vivo as evidenced by reduced α-SMA (myofibroblast marker) immunostaining in vivo. Dotted outlines drawn around the VF lamina propria for each representative image. *=p<0.05, **=p<0.01

    Article Snippet: Picrosirius red was purchased from StatLab (McKinney, TX).

    Techniques: Injection, Binding Assay, Staining, Light Microscopy, Activation Assay, In Vivo, Marker, Immunostaining

    An AAV.CPP.16-mediated gene therapy for idiopathic pulmonary fibrosis (A) Schematic diagram illustrating design of a bifunctional fusion protein that inhibits VEGF and TGF-β1 and construction of an AAV vector expressing such a protein. (B) Experimental design for testing the AAV.CPP.16 gene therapy (CPP.16-IPF trap) in a bleomycin-induced IPF mouse model. i.t., intratracheal; inhal., Inhaled; i.g., intragastric. (C) Representative H&E staining on lung sections in mice with different treatments. Scale bar: 200 μm for low-magnification images and 50 μm for enlarged images. (D) Quantification of lung cell areas in H&E-stained lung sections. n = 3–6 per group, mean ± SEM, one-way ANOVA with Tukey’s post-test. (E) Representative Masson, picrosirius red, and αSMA immunohistochemical staining of lung sections in mice with different treatments. Masson (blue) and picrosirius red (red) stainings label collagen expression. Scale bar: 200 μm. (F) Quantification of fibrotic areas on lung sections. n = 3–6 per group, mean ± SEM, one-way ANOVA with Tukey’s post-test. ∗ p < 0.05, ∗∗ p < 0.01, ∗∗∗ p < 0.001. PBS, phosphate-buffered saline; BLM, bleomycin; IPF, idiopathic pulmonary fibrosis; PFD, pirfenidone; H&E, hematoxylin and eosin.

    Journal: Cell Reports Medicine

    Article Title: Cross-species tropism of AAV.CPP.16 in the respiratory tract and its gene therapies against pulmonary fibrosis and viral infection

    doi: 10.1016/j.xcrm.2025.102144

    Figure Lengend Snippet: An AAV.CPP.16-mediated gene therapy for idiopathic pulmonary fibrosis (A) Schematic diagram illustrating design of a bifunctional fusion protein that inhibits VEGF and TGF-β1 and construction of an AAV vector expressing such a protein. (B) Experimental design for testing the AAV.CPP.16 gene therapy (CPP.16-IPF trap) in a bleomycin-induced IPF mouse model. i.t., intratracheal; inhal., Inhaled; i.g., intragastric. (C) Representative H&E staining on lung sections in mice with different treatments. Scale bar: 200 μm for low-magnification images and 50 μm for enlarged images. (D) Quantification of lung cell areas in H&E-stained lung sections. n = 3–6 per group, mean ± SEM, one-way ANOVA with Tukey’s post-test. (E) Representative Masson, picrosirius red, and αSMA immunohistochemical staining of lung sections in mice with different treatments. Masson (blue) and picrosirius red (red) stainings label collagen expression. Scale bar: 200 μm. (F) Quantification of fibrotic areas on lung sections. n = 3–6 per group, mean ± SEM, one-way ANOVA with Tukey’s post-test. ∗ p < 0.05, ∗∗ p < 0.01, ∗∗∗ p < 0.001. PBS, phosphate-buffered saline; BLM, bleomycin; IPF, idiopathic pulmonary fibrosis; PFD, pirfenidone; H&E, hematoxylin and eosin.

    Article Snippet: Picrosirius red staining , Servicebio , Cat# G1078.

    Techniques: Plasmid Preparation, Expressing, Staining, Immunohistochemical staining, Saline

    ( a ) F-ε z fitting before (red) and after (green) apparent Poisson’s ratio correction. ( b ) Lateral strain ε x as a function of compressive strain ε z . The red and green curves represent the computed lateral strain assuming incompressibility and compressibility, respectively. The black dots were obtained from the CS image segmentation and shape analysis. Error bars represent standard deviation ( n = 6), ( c ) Sensitivity of the apparent modulus calculated at 0.5 μm/s displacement rate to variations in apparent Poisson’s ratio, ( d ) Confocal fluorescence images of a CS composed of human primary cardiac fibroblasts, stained with BioTracker 488 (cell body, green), Hoechst 33342 (cell nuclei, blue) and Picrosirius red (collagen fibrils, red). Showing a maximum intensity projection of a 70 μm z-stack.

    Journal: Scientific Reports

    Article Title: Cell spheroid micromechanics under large deformations

    doi: 10.1038/s41598-025-03676-3

    Figure Lengend Snippet: ( a ) F-ε z fitting before (red) and after (green) apparent Poisson’s ratio correction. ( b ) Lateral strain ε x as a function of compressive strain ε z . The red and green curves represent the computed lateral strain assuming incompressibility and compressibility, respectively. The black dots were obtained from the CS image segmentation and shape analysis. Error bars represent standard deviation ( n = 6), ( c ) Sensitivity of the apparent modulus calculated at 0.5 μm/s displacement rate to variations in apparent Poisson’s ratio, ( d ) Confocal fluorescence images of a CS composed of human primary cardiac fibroblasts, stained with BioTracker 488 (cell body, green), Hoechst 33342 (cell nuclei, blue) and Picrosirius red (collagen fibrils, red). Showing a maximum intensity projection of a 70 μm z-stack.

    Article Snippet: CSs were stained using cell body BioTracker green stain (Sigma-Aldrich, 5μM), Hoechst 33342 stain (Thermo Fisher Scientific, 10 μg/mL) and Picrosirius Red (Morphisto, 0.1% Sirius red in saturated picric acid), according to manufacturer’s protocols.

    Techniques: Standard Deviation, Fluorescence, Staining